Victoria's next generation of world-leading researchers will receive the support they need to continue the fight against cancer.
Victorian Cancer Agency Cancer Health Services Research grants
As part of the Victorian Government’s Victoria Cancer Action Plan 2016-2020, five of the state’s most brilliant scientific minds will receive $1.5 million in grants to support their ground-breaking discoveries and medical breakthroughs in cancer research.
The grants, provided by the Victorian Cancer Agency Cancer, will arm the state’s best medical research experts with the tools and resources they need to develop new ways to treat cancer, ultimately working their way towards finding a cure.
This year’s recipients are all women and will be supported to study the prevention of cancer-associated blood clots, reduce medication errors, develop guidelines for treating cancer-related fatigue and reduce complications from childhood cancer treatment.
Victoria-USA Fellowship Exchange Program
In addition to the grants, the Victorian Government will also be sending three leading Victorian cancer researchers to the United States to train with the world’s preeminent scientists at the prestigious National Cancer Institute.
Dr Anna Ugalde, Dr Wee Loon Ong and Dr Catherine Huggins have each been awarded $10,000 in scholarships to bring their newly acquired skills, knowledge and expertise back home to Victoria.
Australia Japan Medical Research Symposium trade mission
Victorian Government through Global Victoria, and with the support of the National Health and Medical Research Council will coordinate a trade mission for early-career rare cancer researchers to travel to Japan in September and participate in medical symposiums in Tokyo and Osaka.
A key opportunity will be to establish potential collaborations with researchers in Japan with a view to preparing joint funding applications and possible exchanges in the future.
Want to know more?
To find out more information about this trade mission, including how to apply, visit our page on the Australia Japan Medical Research Symposium.
Victoria's capabilities in clinical research and therapeutics
Melbourne’s cancer research capabilities have been pivotal in the development of several new anti-cancer drugs such as AbbVie’s VENCLEXTA™, which was based on original research discoveries at the Walter and Eliza Hall Institute (WEHI). Together with AbbVie and Genentech, WEHI developed a drug development program, progressing to its first clinical trials being conducted at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre.
More people are surviving cancer than ever before. The five-year survival rate for Victorians diagnosed with cancer has increased from 48 per cent in 1986 to 68 per cent in 2016 thanks to major advances in cancer prevention, treatment and research.
Under the Victoria Cancer Plan 2016-2020, the long-term goals of the Victorian Government include:
- halving the proportion of Victorians diagnosed with preventable cancers
- doubling the improvement in one- and five-year survival of Victorians with cancer
- ensuring Victorians have the best possible experience of the cancer treatment and care system
- achieving equitable outcomes for all Victorians.